We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals
AGIO

72 hedge funds and large institutions have $242M invested in Agios Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 72 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
+72
Holders Change %
–
% of All Funds
2.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
72
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$61.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$30.3M
3
Franklin Resources
Franklin Resources
California
+$17.4M
4
BCPEM
Bain Capital Public Equity Management
Massachusetts
+$14.4M
5
Morgan Stanley
Morgan Stanley
New York
+$7.81M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
26
UBS AM
Illinois
$1.81M +$1.79M +64,900 New
State Street
27
State Street
Massachusetts
$1.58M +$1.57M +56,700 New
RG
28
Redmile Group
California
$1.49M +$1.47M +53,100 New
MSA
29
Mason Street Advisors
Wisconsin
$1.48M +$1.46M +53,020 New
Principal Financial Group
30
Principal Financial Group
Iowa
$1.12M +$1.1M +40,000 New
QF
31
QVT Financial
New York
$1.12M +$1.1M +40,000 New
WSA
32
Wall Street Associates
California
$1.11M +$1.1M +39,876 New
Geode Capital Management
33
Geode Capital Management
Massachusetts
$1.06M +$1.04M +37,828 New
Northern Trust
34
Northern Trust
Illinois
$995K +$983K +35,593 New
VAM
35
Visium Asset Management
New York
$995K +$983K +35,600 New
Adage Capital Partners
36
Adage Capital Partners
Massachusetts
$909K +$897K +32,500 New
JP Morgan Chase
37
JP Morgan Chase
New York
$858K +$847K +30,675 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$847K +$836K +30,270 New
HHC
39
Hutchin Hill Capital
New York
$699K +$690K +25,000 New
BG
40
BlackRock Group
United Kingdom
$661K +$652K +23,629 New
Jane Street
41
Jane Street
New York
$614K +$607K +21,976 New
UOC
42
UBS O'Connor
Illinois
$559K +$552K +20,000 New
Bank of New York Mellon
43
Bank of New York Mellon
New York
$547K +$539K +19,527 New
BIM
44
BlackRock Investment Management
Delaware
$531K +$524K +18,978 New
TC
45
TFS Capital
Pennsylvania
$530K +$524K +18,972 New
TRSOTSOK
46
Teachers Retirement System of the State of Kentucky
Kentucky
$497K +$490K +17,760 New
MWNA
47
Marshall Wace North America
New York
$495K +$489K +17,711 New
TCIM
48
TIAA CREF Investment Management
New York
$473K +$467K +16,932 New
EEG
49
E.E. Geduld
$447K +$442K +16,000 New
NFA
50
Nationwide Fund Advisors
Ohio
$441K +$436K +15,785 New
1
2
3

AGIO Hedge Fund Activity: Q3 2013 in Review

72 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q3 2013, worth a combined $242M.

Buyers outnumbered sellers: 72 funds opened new AGIO positions and 0 closed out — a net gain of 72 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $61.6M.

  • 72 institutional investors held Agios Pharmaceuticals (AGIO) as of Q3 2013, up from 0 in Q2 2013.
  • Funds reported $242M of Agios Pharmaceuticals stock for Q3 2013.
  • 72 funds opened new Agios Pharmaceuticals positions in Q3 2013 and 0 closed out, a net change of +72 holders.
  • The largest Agios Pharmaceuticals buyer in Q3 2013 was Fidelity Investments, an estimated $61.6M added.

Based on aggregated 13F filings for Q3 2013.